Immunology

"Immuno-based targeted therapies will minimise the use of steroids" - Photo: R. Ragu GREETING THE VISITOR: K. Mathangi Ramakrishnan, chairperson, CHILDS Trust Medical Research Foundation, with A. V. Ramanan, ...  

Get your biology help with the rapid learning courses - “Teach Yourself Microbiology or Immunology Visually in 24 Hours”. Check it out at Rapid Learning Center - Microbiology and Immunology.  

Research published in the journal Cancer Immunology, Immunotherapy reports that a new anti-tumor vaccine for neuroblastoma and melanoma is significantly impacting tumor growth in mice. The vaccine represents a more personal approach to treatment since it uses the tumor's own protein to induce an...  

Empower yourself with Rapid Learning. Get your immunology help with the rapid learning online course – “Teach Yourself Immunology Visually in 24 Hours”. Check it out at Rapid Learning Center –Immunology.  

Immunology is a visual science, which is best learned visually. The new way of learning is via visual rich-media. With rich-media via visualization, animation and illustration, coupling expert narration, this can enable you to teach yourself Immunology visually and rapidly.  

A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the...  

Immunology is a visual science, which is best learned visually. The new way of learning is via visual rich-media. With rich-media via visualization, animation and illustration, coupling expert narration, this can enable you to teach yourself Immunology visually and rapidly – the Immunology review...  

( Children's National Medical Center ) A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice...  

Data published online in the current edition of Journal of Clinical Immunology demonstrates that Privigen™, the new liquid immune globulin intravenous (human) 10 percent product from CSL Behring, is effective and well-tolerated in patients with Primary Immune Deficiencies (PI).  

A novel anti-tumor vaccine for neuroblastoma and melanoma is showing significant impact on tumor growth in mice, according to new research published in Cancer Immunology, Immunotherapy. The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized...  

From Washington - According to research in the journal Cancer Immunology, Immunotherapy, a new anti-tumor vaccine for neuroblastoma and melanoma is showing ...  

A recent study published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.  

BERN, Switzerland----Not for US or UK media  

A recent study (doi:10.1016/j.clim.2008.06.009) published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.  

Immunologists and tumor immunologists from around the world will gather for three days in New York City next week at the Millennium Conference Center near Times Square for the Cancer Research Institute's 16th International Cancer Immunotherapy Symposium to share the latest data from laboratory...